Cleared Traditional

K230926 - Ova+ (K-OVAP-USA)

K230926 is an FDA 510(k) clearance for Ova+ (K-OVAP-USA), manufactured by Tenscare, Ltd.. The device is a Class 2 Neurology device with product code NUH cleared through the Traditional 510(k) pathway after a 256-day FDA review.

K230926 · Tenscare, Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
256d
Days
Class 2
Risk

K230926 is an FDA 510(k) clearance for the Ova+ (K-OVAP-USA). Classified as Stimulator, Nerve, Transcutaneous, Over-the-counter (product code NUH), Class II - Special Controls.

Submitted by Tenscare, Ltd. (Epsom, GB). The FDA issued a Cleared decision on December 15, 2023 after a review of 256 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Tenscare, Ltd. devices

FDA 510(k) Submission Details - K230926

510(k) Number K230926 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2023
Decision Date December 15, 2023
Days to Decision 256 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
108d slower than avg
Panel avg: 148d · This submission: 256d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NUH Device Classification - Class 2, Special Controls

Product Code NUH Stimulator, Nerve, Transcutaneous, Over-the-counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
Definition Temporary Relief Of Pain Due To Sore/aching Muscles
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NUH Stimulator, Nerve, Transcutaneous, Over-the-counter

All 149
Devices cleared under the same product code (NUH) and FDA review panel - the closest regulatory comparables to K230926.
Pain Therapy Device (SM9075, SM9910, SM9067, SM9587W)
K233092 · Chongqing Rob Linka Science and Technology Co., Ltd. · Feb 2024
Combo Electrotherapy Device (Models: R-C101C, R-C101D, R-C101F, R-C101G, F100, MINI-TENS-COMB, RC101I, TENS3500)
K231423 · Shenzhen Roundwhale Technology Co. , Ltd. · Jan 2024
Hi-Dow PRO TOUCH WIRELESS 6-12 (HD-19A)
K233461 · Hi-Dow International, Inc. · Jan 2024
Transcutaneous Electrical Nerve Stimulator For Pain Relief (Model: KTR-2302, KTR-2401, KTR-2402, KTR-2411, KTR-2412)
K232517 · Shenzhen Kentro Medical Electronics Co., Ltd. · Dec 2023
ManaFlexx 2 (model: MF002-RX, MF002-OTC)
K231569 · Manamed, Inc. · Nov 2023
Heating Tens, FT-615
K232675 · Hivox Biotek, Inc. · Oct 2023